Related Experiment Video
Updated: Aug 5, 2025

09:22
A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
Published on: June 22, 2015
14.7K
The NK1 antagonist L-733,060 facilitates sequence learning
Natalia Favila1,2, Kevin Gurney1, Paul G Overton1
1Department of Psychology, The University of Sheffield, Sheffield, UK.
Journal of Psychopharmacology (Oxford, England)
|March 29, 2023
Summary
Substance P (SP) modulates sequence learning by affecting how the brain updates value estimates based on reward prediction errors. Blocking NK1 receptors impairs sequence retention but speeds up new sequence learning.
Area of Science:
- Neuroscience
- Behavioral Neuroscience
- Computational Neuroscience
Background:
- Sequence learning involves various brain regions and electrophysiological patterns.
- The specific roles of neuromodulators in sequence learning remain underexplored.
Purpose of the Study:
- To investigate the role of substance P (SP) in sequence learning.
- To examine the effects of NK1 receptor antagonism on learning and performing action sequences.
- To model these effects using a reinforcement learning framework.
Main Methods:
- Two experiments using rats trained on action sequences, with NK1 receptor antagonist or vehicle administration.
- Phase 2 involved either reversing the sequence or continuing with the same sequence.
- Development of a reinforcement learning model to simulate experimental tasks.
Main Results:
- NK1 receptor antagonism weakened the retention of well-learned sequences.
- Faster acquisition of new sequences was observed with NK1 receptor antagonism.
- Continued performance of established sequences was not impaired by the antagonist.
- A reinforcement learning model suggested SP modulates state value learning rate via reward prediction error.
Conclusions:
- Substance P (SP) appears to be involved in consolidating sequence representations.
- SP may exert its influence through a modulatory effect on reward prediction error signals.
Related Concept Videos
Long-term Potentiation
2.8K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.8K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
172
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
172

